AnaptysBio, Inc. (ANAB)
52.83
-2.08
(-3.79%)
USD |
NASDAQ |
Mar 03, 16:00
52.83
0.00 (0.00%)
After-Hours: 16:35
AnaptysBio Market Cap : 1.463B for March 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 462.82M |
| Nektar Therapeutics | 1.178B |
| Rigel Pharmaceuticals, Inc. | 598.63M |
| AbbVie, Inc. | 413.49B |
| Esperion Therapeutics, Inc. | 693.28M |
Market Cap Related Metrics
| PS Ratio | 9.268 |
| Price | 52.83 |
| Earnings Yield | -5.34% |